Loading…
Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders
Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this...
Saved in:
Published in: | Journal of clinical medicine 2022-10, Vol.11 (21), p.6400 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823 |
---|---|
cites | cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823 |
container_end_page | |
container_issue | 21 |
container_start_page | 6400 |
container_title | Journal of clinical medicine |
container_volume | 11 |
creator | Horigian, Viviana E Schmidt, Renae D Shmueli-Blumberg, Dikla Hefner, Kathryn Feinberg, Judith Kondapaka, Radhika Feaster, Daniel J Duan, Rui Gonzalez, Sophia Davis, Carly Marín-Navarrete, Rodrigo Tross, Susan |
description | Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events (
= 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies. |
doi_str_mv | 10.3390/jcm11216400 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9657076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2735873555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</originalsourceid><addsrcrecordid>eNpdkc1LxDAQxYMo7qKevEvAiyCrk6RN0osgfoOwou45pEmqWdpGk1bxv7fL6rI6MMzA_Hi84SG0T-CEsQJO56YhhBKeAWygMQUhJsAk21zbR2gvpTkMJWVGidhGI8YZp5zKMXp86r3xVte--8I6YY0forPedCHiUOHph4s2JId1E9oX_KA779ou4U_fveKnvkydbo3Ds4G49ClE62LaRVuVrpPb-5k7aHZ99XxxO7mf3txdnN9PTAZFNymFtNyWlSstlU5WOS80q4BbSjIqoCoBSimNlYSwzBgAQZlhuuAmr0otKdtBZ0vdt75snDWDsahr9RZ9o-OXCtqrv5fWv6qX8KEKngsQfBA4-hGI4b13qVONT8bVtW5d6JOiguVy6Dwf0MN_6Dz0sR3eW1AZZyDJgjpeUiaGlKKrVmYIqEVcai2ugT5Y979if8Nh34W4kI0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2734630815</pqid></control><display><type>article</type><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</creator><creatorcontrib>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</creatorcontrib><description>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events (
= 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11216400</identifier><identifier>PMID: 36362628</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical trials ; Drug abuse ; Drug overdose ; Drug use ; Fatalities ; Heroin ; Hospitalization ; Mental disorders ; Mental health ; Narcotics ; Patients ; Pessimism ; Post traumatic stress disorder ; Respiratory distress syndrome ; Substance abuse treatment ; Substance use disorder ; Suicidal behavior ; Suicides & suicide attempts</subject><ispartof>Journal of clinical medicine, 2022-10, Vol.11 (21), p.6400</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</citedby><cites>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</cites><orcidid>0000-0002-0788-5767 ; 0000-0002-6084-8199 ; 0000-0002-3578-0014 ; 0000-0002-0390-0712 ; 0000-0003-4206-7214 ; 0000-0002-6172-7460</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2734630815/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2734630815?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36362628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horigian, Viviana E</creatorcontrib><creatorcontrib>Schmidt, Renae D</creatorcontrib><creatorcontrib>Shmueli-Blumberg, Dikla</creatorcontrib><creatorcontrib>Hefner, Kathryn</creatorcontrib><creatorcontrib>Feinberg, Judith</creatorcontrib><creatorcontrib>Kondapaka, Radhika</creatorcontrib><creatorcontrib>Feaster, Daniel J</creatorcontrib><creatorcontrib>Duan, Rui</creatorcontrib><creatorcontrib>Gonzalez, Sophia</creatorcontrib><creatorcontrib>Davis, Carly</creatorcontrib><creatorcontrib>Marín-Navarrete, Rodrigo</creatorcontrib><creatorcontrib>Tross, Susan</creatorcontrib><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events (
= 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</description><subject>Clinical trials</subject><subject>Drug abuse</subject><subject>Drug overdose</subject><subject>Drug use</subject><subject>Fatalities</subject><subject>Heroin</subject><subject>Hospitalization</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Narcotics</subject><subject>Patients</subject><subject>Pessimism</subject><subject>Post traumatic stress disorder</subject><subject>Respiratory distress syndrome</subject><subject>Substance abuse treatment</subject><subject>Substance use disorder</subject><subject>Suicidal behavior</subject><subject>Suicides & suicide attempts</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LxDAQxYMo7qKevEvAiyCrk6RN0osgfoOwou45pEmqWdpGk1bxv7fL6rI6MMzA_Hi84SG0T-CEsQJO56YhhBKeAWygMQUhJsAk21zbR2gvpTkMJWVGidhGI8YZp5zKMXp86r3xVte--8I6YY0forPedCHiUOHph4s2JId1E9oX_KA779ou4U_fveKnvkydbo3Ds4G49ClE62LaRVuVrpPb-5k7aHZ99XxxO7mf3txdnN9PTAZFNymFtNyWlSstlU5WOS80q4BbSjIqoCoBSimNlYSwzBgAQZlhuuAmr0otKdtBZ0vdt75snDWDsahr9RZ9o-OXCtqrv5fWv6qX8KEKngsQfBA4-hGI4b13qVONT8bVtW5d6JOiguVy6Dwf0MN_6Dz0sR3eW1AZZyDJgjpeUiaGlKKrVmYIqEVcai2ugT5Y979if8Nh34W4kI0</recordid><startdate>20221029</startdate><enddate>20221029</enddate><creator>Horigian, Viviana E</creator><creator>Schmidt, Renae D</creator><creator>Shmueli-Blumberg, Dikla</creator><creator>Hefner, Kathryn</creator><creator>Feinberg, Judith</creator><creator>Kondapaka, Radhika</creator><creator>Feaster, Daniel J</creator><creator>Duan, Rui</creator><creator>Gonzalez, Sophia</creator><creator>Davis, Carly</creator><creator>Marín-Navarrete, Rodrigo</creator><creator>Tross, Susan</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0788-5767</orcidid><orcidid>https://orcid.org/0000-0002-6084-8199</orcidid><orcidid>https://orcid.org/0000-0002-3578-0014</orcidid><orcidid>https://orcid.org/0000-0002-0390-0712</orcidid><orcidid>https://orcid.org/0000-0003-4206-7214</orcidid><orcidid>https://orcid.org/0000-0002-6172-7460</orcidid></search><sort><creationdate>20221029</creationdate><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><author>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical trials</topic><topic>Drug abuse</topic><topic>Drug overdose</topic><topic>Drug use</topic><topic>Fatalities</topic><topic>Heroin</topic><topic>Hospitalization</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Narcotics</topic><topic>Patients</topic><topic>Pessimism</topic><topic>Post traumatic stress disorder</topic><topic>Respiratory distress syndrome</topic><topic>Substance abuse treatment</topic><topic>Substance use disorder</topic><topic>Suicidal behavior</topic><topic>Suicides & suicide attempts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horigian, Viviana E</creatorcontrib><creatorcontrib>Schmidt, Renae D</creatorcontrib><creatorcontrib>Shmueli-Blumberg, Dikla</creatorcontrib><creatorcontrib>Hefner, Kathryn</creatorcontrib><creatorcontrib>Feinberg, Judith</creatorcontrib><creatorcontrib>Kondapaka, Radhika</creatorcontrib><creatorcontrib>Feaster, Daniel J</creatorcontrib><creatorcontrib>Duan, Rui</creatorcontrib><creatorcontrib>Gonzalez, Sophia</creatorcontrib><creatorcontrib>Davis, Carly</creatorcontrib><creatorcontrib>Marín-Navarrete, Rodrigo</creatorcontrib><creatorcontrib>Tross, Susan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horigian, Viviana E</au><au>Schmidt, Renae D</au><au>Shmueli-Blumberg, Dikla</au><au>Hefner, Kathryn</au><au>Feinberg, Judith</au><au>Kondapaka, Radhika</au><au>Feaster, Daniel J</au><au>Duan, Rui</au><au>Gonzalez, Sophia</au><au>Davis, Carly</au><au>Marín-Navarrete, Rodrigo</au><au>Tross, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-10-29</date><risdate>2022</risdate><volume>11</volume><issue>21</issue><spage>6400</spage><pages>6400-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events (
= 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36362628</pmid><doi>10.3390/jcm11216400</doi><orcidid>https://orcid.org/0000-0002-0788-5767</orcidid><orcidid>https://orcid.org/0000-0002-6084-8199</orcidid><orcidid>https://orcid.org/0000-0002-3578-0014</orcidid><orcidid>https://orcid.org/0000-0002-0390-0712</orcidid><orcidid>https://orcid.org/0000-0003-4206-7214</orcidid><orcidid>https://orcid.org/0000-0002-6172-7460</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2022-10, Vol.11 (21), p.6400 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9657076 |
source | PMC (PubMed Central); Publicly Available Content (ProQuest) |
subjects | Clinical trials Drug abuse Drug overdose Drug use Fatalities Heroin Hospitalization Mental disorders Mental health Narcotics Patients Pessimism Post traumatic stress disorder Respiratory distress syndrome Substance abuse treatment Substance use disorder Suicidal behavior Suicides & suicide attempts |
title | Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suicidality%20as%20a%20Predictor%20of%20Overdose%20among%20Patients%20with%20Substance%20Use%20Disorders&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Horigian,%20Viviana%20E&rft.date=2022-10-29&rft.volume=11&rft.issue=21&rft.spage=6400&rft.pages=6400-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11216400&rft_dat=%3Cproquest_pubme%3E2735873555%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2734630815&rft_id=info:pmid/36362628&rfr_iscdi=true |